Genomics Core Facility
The Genomics Core Facility prepares and sequences DNA libraries for Next Generation Sequencing, including whole genomes and whole transcriptomes. It also prepares nucleic acids from single cells for genomic analysis.
Immune Defense Core Facility
The Immune Defense Core Facility provides centralized services, training, access, and support to researchers in the usage of flow cytometry equipment and related services including technical training opportunities.
RCMI Biophotonics Core Facility
The RCMI Biophotonics Core Facility provides cutting edge technology for the study and manipulation of biological samples using light, including long-term in-depth imaging of live tissues and the technology to probe at the molecular level for protein-protein interactions within live samples.
RCMI Computational Systems Biology Core Facility
The RCMI Computational Systems Biology Core Facility provides computational support for basic and translational health research, including computational infrastructure to support modeling and simulation of biological systems, live cell imaging, and protein biomarker research. The facility provides hardware, software, and programming scripting support, as well as computational research expertise.
RCMI Nanotechnology and Human Health Core Facility
The RCMI Nanotechnology and Human Health Core Facility focuses on the synthesis and characterization of nanomaterials for imaging, labels for bioassays, and active targeting for in vivo or in vitro diagnostics. The Core studies the interaction of nanoparticles with living cells for application in the targeted delivery of drugs, genes, and proteins; tissue engineering scaffolds; artificial organs and implants; and bioimaging and cell labeling.
RCMI Proteomics and Protein Biomarkers Core Facility
The RCMI Proteomics and Protein Biomarkers Core Facility is focused on capillary liquid chromatography-mass spectrometry (LC/MS) and -tandem mass spectrometry (LC/MS/MS) to identify, characterize, and quantify proteins. The Proteomics Core develops novel methods, while the Protein Biomarkers Core applies these methods to discover and validate novel protein biomarkers of disease.